Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection (BJI): tolerance, efficacy and experience with subcutaneous (SC) administration | Zendy

AI Assistant Blog Pricing

Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection (BJI): tolerance, efficacy and experience with subcutaneous (SC) administration

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.